Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
GlucoTrack ( (GCTK) ) just unveiled an update.
Glucotrack, Inc. recently concluded a $10 million public offering and a concurrent private placement converting $4 million of outstanding debt into equity. The offering involved shares, pre-funded warrants, and series A and B common warrants, with proceeds earmarked for working capital and corporate purposes. The company aims to meet Nasdaq’s stockholders’ equity requirements, crucial for maintaining its listing. This strategic move highlights Glucotrack’s commitment to advancing its pioneering diabetes technologies while addressing financial compliance challenges.
Find detailed analytics on GCTK stock on TipRanks’ Stock Analysis page.
